Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Johnson & Johnson Dividend Announcement
• Johnson & Johnson announced a quarterly dividend of $1.24 per ordinary share which will be made payable on 2024-12-10. Ex dividend date: 2024-11-26
• Johnson & Johnson annual dividend for 2024 was $4.91
• Johnson & Johnson annual dividend for 2023 was $4.70
• Johnson & Johnson's trailing twelve-month (TTM) dividend yield is 3.17%
• Johnson & Johnson's payout ratio for the trailing twelve months (TTM) is 79.71%
• Johnson & Johnson's dividend growth over the last five years (2018-2023) was 5.83% year
• Johnson & Johnson's dividend growth over the last ten years (2013-2023) was 6.14% year
Johnson & Johnson Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-26 | $1.24 | quarterly | 2024-12-10 |
2024-08-27 | $1.24 | quarterly | 2024-09-10 |
2024-05-20 | $1.24 | quarterly | 2024-06-04 |
2024-02-16 | $1.19 | quarterly | 2024-03-05 |
2023-11-20 | $1.19 | quarterly | 2023-12-05 |
2023-08-25 | $1.19 | quarterly | 2023-09-07 |
2023-05-22 | $1.19 | quarterly | 2023-06-06 |
2023-02-17 | $1.13 | quarterly | 2023-03-07 |
2022-11-21 | $1.13 | quarterly | 2022-12-06 |
2022-08-22 | $1.13 | quarterly | 2022-09-06 |
2022-05-23 | $1.13 | quarterly | 2022-06-07 |
2022-02-18 | $1.06 | quarterly | 2022-03-08 |
2021-11-22 | $1.06 | quarterly | 2021-12-07 |
2021-08-23 | $1.06 | quarterly | 2021-09-07 |
2021-05-24 | $1.06 | quarterly | 2021-06-08 |
2021-02-22 | $1.01 | quarterly | 2021-03-09 |
2020-11-23 | $1.01 | quarterly | 2020-12-08 |
2020-08-24 | $1.01 | quarterly | 2020-09-08 |
2020-05-22 | $1.01 | quarterly | 2020-06-09 |
2020-02-24 | $0.95 | quarterly | 2020-03-10 |
2019-11-25 | $0.95 | quarterly | 2019-12-10 |
2019-08-26 | $0.95 | quarterly | 2019-09-10 |
2019-05-24 | $0.95 | quarterly | 2019-06-11 |
2019-02-25 | $0.90 | quarterly | 2019-03-12 |
2018-11-26 | $0.90 | quarterly | 2018-12-11 |
2018-08-27 | $0.90 | quarterly | 2018-09-11 |
2018-05-25 | $0.90 | quarterly | 2018-06-12 |
2018-02-26 | $0.84 | quarterly | 2018-03-13 |
2017-11-27 | $0.84 | quarterly | 2017-12-12 |
2017-08-25 | $0.84 | quarterly | 2017-09-12 |
2017-05-25 | $0.84 | quarterly | 2017-06-13 |
2017-02-24 | $0.80 | quarterly | 2017-03-14 |
2016-11-18 | $0.80 | quarterly | 2016-12-06 |
2016-08-19 | $0.80 | quarterly | 2016-09-06 |
2016-05-20 | $0.80 | quarterly | 2016-06-07 |
2016-02-19 | $0.75 | quarterly | 2016-03-08 |
2015-11-20 | $0.75 | quarterly | 2015-12-08 |
2015-08-21 | $0.75 | quarterly | 2015-09-08 |
2015-05-21 | $0.75 | quarterly | 2015-06-09 |
2015-02-20 | $0.70 | quarterly | 2015-03-10 |
2014-11-21 | $0.70 | quarterly | 2014-12-09 |
2014-08-22 | $0.70 | quarterly | 2014-09-09 |
2014-05-22 | $0.70 | quarterly | 2014-06-10 |
2014-02-21 | $0.66 | quarterly | 2014-03-11 |
2013-11-22 | $0.66 | quarterly | 2013-12-10 |
2013-08-23 | $0.66 | quarterly | 2013-09-10 |
2013-05-23 | $0.66 | quarterly | 2013-06-11 |
2013-02-22 | $0.61 | quarterly | 2013-03-12 |
Johnson & Johnson Dividend per year
Johnson & Johnson Dividend growth
Johnson & Johnson Dividend Yield
Johnson & Johnson current trailing twelve-month (TTM) dividend yield is 3.17%. Interested in purchasing Johnson & Johnson stock? Use our calculator to estimate your expected dividend yield:
Johnson & Johnson Financial Ratios
Johnson & Johnson Dividend FAQ
Other factors to consider when evaluating Johnson & Johnson as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Johnson & Johnson stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Johnson & Johnson's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Johnson & Johnson publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Johnson & Johnson distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Johnson & Johnson are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Johnson & Johnson sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Johnson & Johnson distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Johnson & Johnson declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Johnson & Johnson's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Johnson & Johnson's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.